substance p has been researched along with Skin Neoplasms in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chaney, K; Conniff, T; Cruikshank, W; Curiel-Lewandrowski, C; Tuzova, M; Wolpowitz, D | 1 |
Coveñas, R; González-Ortega, A; Muñoz, M; Robles-Frias, MJ; Rosso, M; Rosso, R; Salinas-Martín, MV | 1 |
Lechago, J; Ordóñez, NG; Silva, EG | 1 |
Albino, AP; Khare, VK; Reed, JA | 1 |
Kitani, S; Mochizuki, M; Morita, Y; Nagase, M; Nishimura, R; Sasaki, N; Takahashi, T | 1 |
Deftos, LJ; Gould, VE; Hoog, A; Martin, EM; Radosevich, JA; Rosen, ST | 1 |
Kishimoto, S; Kobayashi, K; Miyashita, A; Nagatani, H | 1 |
7 other study(ies) available for substance p and Skin Neoplasms
Article | Year |
---|---|
Absence of full-length neurokinin-1 receptor protein expression by cutaneous T cells: implications for substance P-mediated signaling in mycosis fungoides.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Case-Control Studies; Female; Fluorescent Antibody Technique; Humans; Lymphocytes, Tumor-Infiltrating; Male; Middle Aged; Mycosis Fungoides; Prospective Studies; Receptors, Neurokinin-1; Signal Transduction; Skin Neoplasms; Substance P; T-Lymphocytes | 2015 |
The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Aprepitant; Cell Line; Cell Proliferation; Humans; Melanoma; Morpholines; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Skin Neoplasms; Substance P | 2010 |
Immunohistochemical studies in endocrine carcinoma of the skin.
Topics: Adenocarcinoma; Adrenocorticotropic Hormone; Adult; Aged; Carcinoma; Enkephalin, Methionine; Female; Histocytochemistry; Humans; Immunoenzyme Techniques; Male; Microscopy, Electron; Middle Aged; Peptides; Serotonin; Skin; Skin Neoplasms; Somatostatin; Substance P; Terminology as Topic | 1984 |
The neuropeptide/mast cell secretagogue substance P is expressed in cutaneous melanocytic lesions.
Topics: Disease Progression; Dysplastic Nevus Syndrome; Humans; Immunohistochemistry; Mast Cells; Melanoma; Precancerous Conditions; Retrospective Studies; Skin Neoplasms; Substance P | 1998 |
IgG-mediated histamine release from canine mastocytoma-derived cells.
Topics: Animals; Calcimycin; Cell Line; Chymases; Dog Diseases; Dogs; Female; Histamine Release; Immunoglobulin G; Intestinal Neoplasms; Ionophores; Male; Mast Cells; Mast-Cell Sarcoma; Microscopy, Electron; Serine Endopeptidases; Skin Neoplasms; Substance P; Tryptases; Tumor Cells, Cultured | 2001 |
Parathyroid hormone-related protein, chromogranin A, and calcitonin gene products in the neuroendocrine skin carcinoma cell lines MKL1 and MKL2.
Topics: Bombesin; Calcitonin; Calcitonin Gene-Related Peptide; Chromogranin A; Chromogranins; Humans; Microscopy, Electron; Neurosecretory Systems; Parathyroid Hormone-Related Protein; Proteins; Skin Neoplasms; Substance P; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 1991 |
Immunohistochemical demonstration of substance P-containing nerve fibres in glomus tumours.
Topics: Enkephalin, Methionine; Glomus Tumor; Humans; Immunoenzyme Techniques; Myelin Basic Protein; Nerve Fibers; S100 Proteins; Serotonin; Skin Neoplasms; Substance P | 1985 |